Legend Biotech (Legend Biotech) EV-to-Revenue : 26.83 (As of Apr. 24, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Legend Biotech's enterprise value is $7,651.6 Mil. Legend Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $285.1 Mil. Therefore, Legend Biotech's EV-to-Revenue for today is 26.83.

The historical rank and industry rank for Legend Biotech's EV-to-Revenue or its related term are showing as below:

LEGN' s EV-to-Revenue Range Over the Past 10 Years
Min: 26.03 Med: 63.55 Max: 113.64
Current: 26.83

During the past 6 years, the highest EV-to-Revenue of Legend Biotech was 113.64. The lowest was 26.03. And the median was 63.55.

LEGN's EV-to-Revenue is ranked worse than
71.41% of 1032 companies
in the Biotechnology industry
Industry Median: 7.64 vs LEGN: 26.83

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Legend Biotech's stock price is $45.17. Legend Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.60. Therefore, Legend Biotech's PS Ratio for today is 28.16.

Legend Biotech EV-to-Revenue Historical Data

The historical data trend for Legend Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech EV-to-Revenue Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

43.24

93.41

64.09

34.95

Legend Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															64.09	72.06	68.76	47.75	34.95

Competitive Comparison of Legend Biotech's EV-to-Revenue

For the Biotechnology subindustry, Legend Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Legend Biotech's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Legend Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Legend Biotech's EV-to-Revenue falls into.

Legend Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Legend Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	7651.634	/	285.143
	=	26.83

Legend Biotech's current Enterprise Value is $7,651.6 Mil.
Legend Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $285.1 Mil.

Legend Biotech (NAS:LEGN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Legend Biotech's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	45.17	/	1.604
	=	28.16

Legend Biotech's share price for today is $45.17.
Legend Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.60.

Legend Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Legend Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech (Legend Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.